You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

hA20

Showing 1 - 25 of 4,124
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Non-Hodgkin's Lymphoma Trial in New York, Philadelphia, Houston (hA20-humanized anti-CD20 antibody)

Completed
  • Non-Hodgkin's Lymphoma
  • hA20-humanized anti-CD20 antibody
  • New York, New York
  • +2 more
Aug 12, 2021

Non-Hodgkin's Lymphoma, Lymphoma, Diffuse, Lymphoma, Diffuse, Mixed Lymphocytic-Histiocytic Trial in Lille, Lyon, Leicester

Completed
  • Non-Hodgkin's Lymphoma
  • +2 more
  • Lille, Cedex, France
  • +2 more
Aug 12, 2021

Purpura, Thrombocytopenic, Idiopathic, Autoimmune Thrombocytopenic Purpura, Purpura, Thrombocytopenic, Autoimmune Trial in

Terminated
  • Purpura, Thrombocytopenic, Idiopathic
  • +2 more
  • veltuzumab
  • Los Angeles, California
  • +7 more
Aug 12, 2021

NHL, Lymphoma, Non-Hodgkin, Lymphoma, B-Cell Trial in United States (veltuzumab)

Completed
  • NHL
  • +17 more
  • veltuzumab
  • Savannah, Georgia
  • +4 more
Aug 12, 2021

Chronic Wounds Trial in Harbin (HA35(L20200708MP07707, Ministry of Health, Mongolia)was freshly manufactured by mixing

Completed
  • Chronic Wounds
  • HA35(L20200708MP07707, Ministry of Health, Mongolia)was freshly manufactured by mixing hyaluronidase PH20 injectable solution (H31022111) and high-molecular-weight HA injectable solution (H20174089)
  • Harbin, Heilongjiang, China
    Far East Hospital
Mar 1, 2023

Periodontitis Trial in Sanya (HA35(L20200708MP07707, Ministry of Health, Mongolia) was freshly manufactured by mixing

Completed
  • Periodontitis
  • HA35(L20200708MP07707, Ministry of Health, Mongolia) was freshly manufactured by mixing hyaluronidase PH20 injectable solution (H31022111) and high-molecular-weight HA injectable solution (H20174089)
  • Sanya, Hainan, China
    Sanya Central Hospital
Mar 13, 2023

Shoulder Pain, Neck Pain, Back Pain Trial in Qingdao (HA35(L20200708MP07707, Ministry of Health, Mongolia) was freshly

Completed
  • Shoulder Pain
  • +4 more
  • HA35(L20200708MP07707, Ministry of Health, Mongolia) was freshly manufactured by mixing hyaluronidase PH20 injectable solution (H31022111) and high-molecular-weight HA injectable solution (H20174089)
  • Qingdao, Shandong, China
    Qingdao University Affiliated Hospital
Mar 1, 2023

Non Hodgkin's Lymphoma, NHL, Aggressive NHL Trial in United States (Veltuzumab and 90Y-Epratuzumab Tetraxetan, 90Y-epratuzumab

Withdrawn
  • Non Hodgkin's Lymphoma
  • +3 more
  • Veltuzumab and 90Y-Epratuzumab Tetraxetan
  • +2 more
  • Newark, Delaware
  • +6 more
Aug 12, 2021

COVID-19, SARS-CoV-2 Trial in Worldwide (AZD5156, Placebo, AZD7442 (EVUSHELD™))

Recruiting
  • COVID-19, SARS-CoV-2
  • AZD5156
  • +2 more
  • Buenos Aires, Argentina
  • +20 more
Jan 12, 2023

Relapsed or Refractory Multiple Myeloma Trial in Worldwide (JNJ-79635322)

Recruiting
  • Relapsed or Refractory Multiple Myeloma
  • Edegem, Belgium
  • +16 more
Jan 27, 2023

Investigate Adaptation and Evolution of Ovarian High-grade

Recruiting
  • Ovarian Cancer
  • +6 more
    • Bristol, United Kingdom
    • +10 more
    Sep 8, 2022

    Lymphoma Trial in United Kingdom (biological, drug, radiation)

    Terminated
    • Lymphoma
    • rituximab
    • +5 more
    • Manchester, England, United Kingdom
    • +4 more
    Dec 16, 2021

    Carcinosarcoma, Endometrial Tumors Trial in United Kingdom (Paclitaxel, Cediranib, Olaparib)

    Active, not recruiting
    • Carcinosarcoma
    • Endometrial Neoplasms
    • Northwood, Middlesex, United Kingdom
    • +14 more
    Feb 10, 2022

    Migraine Headache Trial in Louisville (Auricular Acupuncture, Ketorolac 0.5mg/kg, max 30mg, Metoclopramide 0.1 mg/kg, max 10mg)

    Recruiting
    • Migraine Headache
    • Auricular Acupuncture
    • +4 more
    • Louisville, Kentucky
    • +1 more
    Jun 17, 2021

    Motor Neuron Disease, Amyotrophic Lateral Sclerosis Trial in United Kingdom (Virtual peer-to-peer support)

    Recruiting
    • Motor Neuron Disease
    • Amyotrophic Lateral Sclerosis
    • Virtual peer-to-peer support
    • Bedford, United Kingdom
    • +14 more
    Aug 16, 2022

    Adv Solid Malig - H&N SCC, ATM Pro / Def NSCLC, Gastric, Breast and Ovarian Cancer Trial in Worldwide (Administration of

    Recruiting
    • Adv Solid Malig - H&N SCC, ATM Pro / Def NSCLC, Gastric, Breast and Ovarian Cancer
    • Administration of ceralasertib in combination with carboplatin
    • +3 more
    • Duarte, California
    • +26 more
    Aug 17, 2022

    Ovarian Cancer, Epithelial, Gastric Cancer, GastroEsophageal Junction (GEJ) Cancer Trial in United Kingdom (NX-1607)

    Recruiting
    • Ovarian Cancer, Epithelial
    • +14 more
    • Sutton, Surrey, United Kingdom
    • +6 more
    Jul 22, 2022

    Lymphoma, Non-Hodgkin Trial in Worldwide (RO7227166, Obinutuzumab, Glofitamab)

    Recruiting
    • Lymphoma, Non-Hodgkin
    • Pasadena, California
    • +14 more
    Jan 30, 2023

    Hepatocellular Cancer, AFP Expressing Tumors Trial in Worldwide (Autologous genetically modified AFP?³³²T cells)

    Active, not recruiting
    • Hepatocellular Cancer
    • AFP Expressing Tumors
    • Autologous genetically modified AFPᶜ³³²T cells
    • Phoenix, Arizona
    • +20 more
    Aug 26, 2022

    Advanced Solid Tumors or Non-Hodgkin's Lymphoma (NHL) Trial in United Kingdom (SRA737)

    Completed
    Has Results
    • Advanced Solid Tumors or Non-Hodgkin's Lymphoma (NHL)
    • Sutton, London, United Kingdom
    • +14 more
    Mar 9, 2022

    Eye Diseases, Macular Degeneration, Wet, Sub-Macular Hemorrhage Trial in United Kingdom (Pars plana vitrectomy, Intravitreal 2

    Recruiting
    • Eye Diseases
    • +2 more
    • Pars plana vitrectomy
    • +3 more
    • Chelmsford, Essex, United Kingdom
    • +13 more
    Aug 2, 2022

    Sarcoma Trial in United Kingdom (radiotherapy)

    Completed
    • Sarcoma
    • radiotherapy
    • Birmingham, England, United Kingdom
    • +5 more
    Mar 17, 2021

    Metastatic Breast Cancer Trial in United States (Eribulin mesylate, Biologic: PEGylated recombinant human hyaluronidase

    Terminated
    Has Results
    • Metastatic Breast Cancer
    • Eribulin mesylate
    • +2 more
    • Whittier, California
    • +6 more
    Jun 25, 2020

    COVID-19, SARS-CoV-2 Trial in Worldwide (AZD1222, AZD2816)

    Active, not recruiting
    • COVID-19
    • SARS-CoV-2
    • AZD1222
    • AZD2816
    • Brasilia, Brazil
    • +34 more
    Jun 27, 2022

    Osteoarthritis, Knee, Osteoarthritis, Hip Trial in Poland, United Kingdom, United States (Fasinumab, Naproxen, Diclofenac)

    Terminated
    • Osteoarthritis, Knee
    • Osteoarthritis, Hip
    • Phoenix, Arizona
    • +14 more
    Aug 24, 2021